Cargando…

Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses

Detalles Bibliográficos
Autores principales: Cinkilic, Okan, Anft, Moritz, Blazquez-Navarro, Arturo, Meister, Toni L., Roch, Toralf, Stervbo, Ulrik, Pfaender, Stephanie, Westhoff, Timm H., Babel, Nina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Society of Nephrology. Published by Elsevier Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920472/
https://www.ncbi.nlm.nih.gov/pubmed/35301007
http://dx.doi.org/10.1016/j.kint.2022.03.005
_version_ 1784669134936604672
author Cinkilic, Okan
Anft, Moritz
Blazquez-Navarro, Arturo
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
author_facet Cinkilic, Okan
Anft, Moritz
Blazquez-Navarro, Arturo
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
author_sort Cinkilic, Okan
collection PubMed
description
format Online
Article
Text
id pubmed-8920472
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher International Society of Nephrology. Published by Elsevier Inc.
record_format MEDLINE/PubMed
spelling pubmed-89204722022-03-15 Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses Cinkilic, Okan Anft, Moritz Blazquez-Navarro, Arturo Meister, Toni L. Roch, Toralf Stervbo, Ulrik Pfaender, Stephanie Westhoff, Timm H. Babel, Nina Kidney Int Letter to the Editor International Society of Nephrology. Published by Elsevier Inc. 2022-06 2022-03-14 /pmc/articles/PMC8920472/ /pubmed/35301007 http://dx.doi.org/10.1016/j.kint.2022.03.005 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Cinkilic, Okan
Anft, Moritz
Blazquez-Navarro, Arturo
Meister, Toni L.
Roch, Toralf
Stervbo, Ulrik
Pfaender, Stephanie
Westhoff, Timm H.
Babel, Nina
Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title_full Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title_fullStr Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title_full_unstemmed Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title_short Inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 SARS-CoV-2 vaccine doses compared with 4 doses
title_sort inferior humoral and sustained cellular immunity against wild-type and omicron variant of concern in hemodialysis patients immunized with 3 sars-cov-2 vaccine doses compared with 4 doses
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8920472/
https://www.ncbi.nlm.nih.gov/pubmed/35301007
http://dx.doi.org/10.1016/j.kint.2022.03.005
work_keys_str_mv AT cinkilicokan inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT anftmoritz inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT blazqueznavarroarturo inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT meistertonil inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT rochtoralf inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT stervboulrik inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT pfaenderstephanie inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT westhofftimmh inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses
AT babelnina inferiorhumoralandsustainedcellularimmunityagainstwildtypeandomicronvariantofconcerninhemodialysispatientsimmunizedwith3sarscov2vaccinedosescomparedwith4doses